SLAYEN HOWARD T 4

4 · AEHR TEST SYSTEMS · Filed Jul 17, 2023

Form 4

Period: 2023-07-14

Director

Transactions

Exercise/Conversion
Common Stock
2023-07-14$2.03/sh+10,000$20,300→ 156,004 total
Exercise/Conversion
Common Stock
2023-07-14$1.86/sh+14,711$27,362→ 196,875 total
Exercise/Conversion
Common Stock
2023-07-14$1.34/sh+10,000$13,400→ 206,875 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-07-14−10,000→ 0 total
Exercise: $1.34From: 2020-11-20Exp: 2027-10-20→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2023-07-14$1.77/sh+10,000$17,700→ 166,004 total
Exercise/Conversion
Common Stock
2023-07-14$1.64/sh+16,160$26,502→ 182,164 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-07-14−16,160→ 0 total
Exercise: $1.64From: 2020-04-21Exp: 2027-04-21→ Common Stock (16,160 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-07-14−14,711→ 0 total
Exercise: $1.86From: 2020-07-14Exp: 2027-07-14→ Common Stock (14,711 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-07-14−10,000→ 0 total
Exercise: $1.77From: 2019-11-22Exp: 2026-10-22→ Common Stock (10,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-07-14−10,000→ 0 total
Exercise: $2.03From: 2018-11-23Exp: 2025-11-23→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]The amount reported includes shares subject to unvested restricted stock units.
[F2]One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter.
[F3]Total number of shares became exercisable on this date.

Documents

2 files